Key details Current limitations: Traditional scar treatments (surgery, gels, steroids) are often only partially effective. Even after treatment, scars frequently remain, presenting aesthetic and functional challenges for patients. New research: A recent review...
Key details New clinical phase: A stem cell therapy called laromestrocel has entered a pivotal Phase 2b clinical trial to treat hypoplastic left heart syndrome (HLHS), a congenital defect where the left heart is severely undeveloped.[1] Standard of care: Treatment for...
Key details Current treatment limitations: While ischaemic strokes – which account for nearly 90% of all strokes – are currently treated with clot removal and supportive rehabilitation, there remains a significant unmet need for therapies that directly address...
Key details Understanding Lesch-Nyhan syndrome: This rare, recessive condition linked to the X chromosome primarily affects boys, and is characterised by a deficiency of the HPRT enzyme, leading to severe motor dysfunction, uric acid overproduction, and compulsive...
Today is World Cord Blood Day! A lot of progress has been made since the very first cord blood transplant was performed in 1988, 37 years ago. Since then, over 60,000 cord blood transplants have been performed worldwide, and donor cord blood stem cells, such as from a...
